The cytotoxic and biological effects of silver diamine fluoride on human dental pulp cells: A systematic review and meta-analysis Authors: Chanchal Kumari, Ruchi Singhal, Ritu Namdev, Adarsh Kumar, Shiwani Chawla, Khusboo Chhanna Published: 2026 ABSTRACT IntroductionSilver diamine fluoride is widely used for non-invasive caries management; however, its biological safety near the dental pulp remains controversial.ObjectiveTo systematically evaluate and quantitatively synthesize evidence on the cytotoxic and biological effects of SDF on human dental pulp cells.MethodsThis PRISMA-compliant systematic review and meta-analysis (PROSPERO: CRD420251166805) included in vitro and ex vivo studies assessing SDF effects on human dental pulp cells. Searches were conducted in PubMed, Scopus, Cochrane CENTRAL, and Google Scholar without date restrictions. Study selection, data extraction, and quality assessment were performed independently by two reviewers. Cell viability outcomes were pooled using random-effects models.ResultsSeven in vitro studies (2022–2024) were included. Qualitative synthesis demonstrated a consistent dose-dependent cytotoxic effect of SDF. Clinically used and high concentrations (≥3.8–38%) caused marked reductions in cell viability. Meta-analysis showed minimal cytotoxicity at very low concentrations (0.00001–0.0005%; pooled effect = 0.99, 95% CI: 0.97–1.00), a significant decline in viability at 0.001–0.005% (pooled effect = 0.73, 95% CI: 0.46–0.93), and severe toxicity at concentrations ≥0.008% (pooled effect = 0.14, 95% CI: 0.00–0.41). Most studies reported IC50 values at or below 0.001%.ConclusionSDF exhibits strong dose-dependent cytotoxicity, with biological safety restricted to very low concentrations. Direct or near-pulpal application of conventional SDF concentrations may pose a risk of pulpal toxicity and should be approached cautiously.Clinical significanceDirect or near-pulpal application of standard SDF concentrations should be avoided. Clinicians should exercise caution in deep carious lesions. Introduction Dental caries remains one of the most prevalent chronic diseases worldwide, affecting individuals across all age groups and posing a significant public health burden. Traditional caries management relies on operative approaches that involve removal of infected tooth structure, which may not always be feasible in young, anxious, medically compromised, or underserved populations. In recent years, silver diamine fluoride (SDF) has emerged as a minimally invasive, cost-effective alternative for arresting dental caries, particularly in primary teeth. Its strong antimicrobial properties and ability to arrest carious lesions without mechanical excavation or local anaesthesia represent a major advancement in non-invasive caries management.1˒2 Despite its clinical advantages, concerns persist regarding the biological safety of SDF, particularly its effects on the dental pulp. When applied to deep carious lesions, SDF can penetrate dentinal tubules and diffuse toward the pulp chamber, potentially exposing dental pulp cells to its bioactive components.3 Experimental studies have demonstrated that direct or indirect exposure of dental pulp cells to SDF may induce a range of biological responses. Several in vitro investigations have reported dose-dependent cytotoxicity, characterized by reduced cell viability, altered morphology, mitochondrial dysfunction, and increased rates of apoptosis and necrosis. Conversely, some studies suggest that SDF may exert protective or regenerative effects when used at controlled concentrations or under indirect exposure conditions. These studies have reported conflicting results regarding SDF cytotoxicity. Variations in study design, SDF concentration, application time, and type of pulp cells used contribute to inconsistencies across the literature. Clinicians must balance the caries-arresting benefits of SDF with potential adverse pulpal responses, making evidence-based conclusions essential for safe clinical decision-making. Although several studies and reviews have examined the interaction between SDF and the dentin–pulp complex,4 the current body of evidence remains fragmented and methodologically diverse. To date, no systematic review incorporating a quantitative meta-analysis has synthesized data specifically addressing the effects of SDF on human dental pulp cells. Previous reports have provided descriptive summaries but lack an integrated statistical assessment capable of determining overall cytotoxicity patterns, dose-response relationships, and sources of variability. Moreover, the earlier review included a mixture of human and animal studies, limiting its ability to draw conclusions specific to human dental pulp cell responses. Therefore, the present systematic review aims to comprehensively evaluate the available evidence regarding the biological effects of SDF on human dental pulp cells and to conduct the first meta-analysis on this topic. The review quantitatively assesses cell viability outcomes and qualitatively synthesizes evidence relating to cytotoxicity, proliferation, inflammatory responses, and oxidative stress in human dental pulp cells. By integrating both qualitative and quantitative findings, this review seeks to clarify the biological profile of SDF on pulpal tissues, support evidence-based clinical decision-making in deep carious lesions, and identify gaps for future research to improve the safety and therapeutic use of SDF. Materials and methods This systematic review was conducted and reported in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines and was registered in the PROSPERO (CRD420251166805) database prior to its initiation. Research question What are the direct cytotoxic and biological effects of silver diamine fluoride (SDF) on human dental pulp cells across different concentrations? Inclusion and exclusion criteria Studies were included if they met the following criteria:•In vitro or ex vivo studies investigating the effects of SDF on human dental pulp cells•Studies published in the English language•Full-text articles available •In vitro or ex vivo studies investigating the effects of SDF on human dental pulp cells In vitro or ex vivo studies investigating the effects of SDF on human dental pulp cells •Studies published in the English language Studies published in the English language •Full-text articles available Full-text articles available Studies were excluded if they:•Focused exclusively on non-pulp tissues•Involved animal models•Were review articles, case reports, editorials, letters, or conference abstracts•Did not specifically assess the effects of SDF on pulpal tissue •Focused exclusively on non-pulp tissues Focused exclusively on non-pulp tissues •Involved animal models Involved animal models •Were review articles, case reports, editorials, letters, or conference abstracts Were review articles, case reports, editorials, letters, or conference abstracts •Did not specifically assess the effects of SDF on pulpal tissue Did not specifically assess the effects of SDF on pulpal tissue Eligibility criteria Population Studies investigating human dental pulp cells, encompassing dental pulp stem cells (DPSCs), stem cells from human exfoliated deciduous teeth (SHEDs), odontoblast-like cells, pulp fibroblasts, and other human-derived pulp cell lines. Intervention Studies that evaluated the effects of SDF at any concentration or formulation. Comparators Studies evaluating the biological effects of SDF on human dental pulp cells, with outcomes assessed relative to corresponding control conditions where available. For quantitative synthesis, studies reporting cell viability data following SDF exposure were included irrespective of the comparator used. Study design Included studies were in vitro or ex vivo experimental studies, both randomized and non-randomized, that quantitatively or qualitatively assessed SDF's cytotoxic or biological effects on human dental pulp cells. In vivo studies were excluded unless they contained a distinct in vitro pulp tissue evaluation. Context Studies conducted in laboratory or experimental research settings focused on the biocompatibility, cytotoxicity, and biological response of human dental pulp cells to SDF exposure. Outcomes The primary outcome was the cytotoxic effect of SDF on human dental pulp cells or tissue, assessed through cell viability assays. Secondary outcomes included evaluation for apoptosis or necrosis, cell proliferation, morphological changes, and odontogenic differentiation markers. Quantitative data were extracted to evaluate dose-dependent effects of SDF exposure. Data sources The literature search was performed in four databases PubMed, Scopus, Cochrane Central Register of Controlled Trials (CENTRAL), and Google Scholar. Search strategy A systematic and comprehensive literature search was conducted to identify studies investigating the cytotoxic effects of SDF on human dental pulp cells. The search strategy was developed using a combination of Medical Subject Headings (MeSH) and free-text terms. Several search combinations were evaluated to maximize search sensitivity and ensure that potentially relevant studies were not missed, all search strategies and the corresponding number of records retrieved are provided in Supplementary Table S1. The following search string was applied uniformly across all selected electronic databases: ("silver diamine fluoride" OR "SDF") AND ("pulp" OR "cell"). The search was restricted to studies involving human dental pulp cells and published in English. No limits were imposed on the year of publication. All records retrieved from the database searches were exported to Zotero (version 7.0.13), where duplicate entries were identified and removed. Titles and abstracts were screened for relevance, followed by full-text assessment of potentially eligible articles. In addition, the reference lists of all included studies were manually screened to identify further relevant publications. When full-text articles were not accessible, corresponding authors were contacted via email to obtain the required information. The final search was updated on October 31, 2025. All methodological steps, including the initial search, screening, eligibility assessment, data extraction, and quality assessment, were performed independently by two reviewers. Any disagreement was resolved by discussion with a third author. Quality assessment The methodological quality of the included studies was evaluated using the ToxRTool (Toxicological Data Reliability Assessment Tool).5 ToxRTool was selected because the included studies primarily investigated the cytotoxic and biological effects of SDF in vitro. It provides a structured and validated framework for assessing the methodological quality and reliability of toxicological studies. The tool consists of 18 scoring questions grouped into five methodological domains: test substance identification (D1), test system characterization (D2), study design description (D3), study results documentation (D4), and plausibility of study design and data (D5). Each criterion is rated as fulfilled or not fulfilled, with a maximum possible score of 18. Based on the total score, studies were classified as reliable without restrictions (15–18), reliable with restrictions (11–14), or not reliable (≤10). Data extraction The data extraction was done using a self-designed data extraction template including study title, author names, objective, cell type, SDF compound, exposure, duration, tests used, and main findings. When necessary, study authors were contacted for clarification or missing information through email. Data synthesis and statistical analysis Qualitative synthesis All included studies were summarized narratively supported by descriptive tabulation emphasizing experimental design, concentration, concentration-dependent effects, and biological responses of pulp cells. Quantitative synthesis Studies reporting quantitative cell viability data were eligible for meta-analysis. Viability values were extracted from graphs or tables using webplotdigitizer. Data extraction was performed independently by two reviewers and repeated to ensure accuracy. Extracted values were cross-checked, and any discrepancies were resolved by mutual agreement. Where numerical values were available in tables, these were used preferentially over graph-derived estimates. A meta-analysis was conducted to quantitatively synthesize the available findings, and the pooled outcomes were graphically represented using a forest plot generated with https://metaanalysisonline.com. Cell viability in the included studies was defined as the percentage of living, metabolically active cells. Meta-analysis was performed using the random-effects model. A random-effects approach was selected because methodological and biological heterogeneity were anticipated among studies, including differences in cell types, SDF formulations, exposure times, and viability assays. Heterogeneity was assessed using the I2 statistic. For analysis, cell viability was treated as an inverse indicator of cytotoxicity, with higher values reflecting lower toxic potential. Statistical heterogeneity was assessed using the I2 statistic, with values of 25%, 50%, and 75% representing low, moderate, and substantial heterogeneity, respectively. For IC50 (half maximal inhibitory concentration) values, for SDF cytotoxicity were determined either directly from fitted dose-response curves or estimated via linear interpolation on a logarithmic concentration scale: LD50 = 10^[log C1 + ((50 - V1)/(V2 - V1)) × (log C2 - log C1)]. Results Study selection The flow of studies through the review process, including the number of records identified, screened, excluded, and finally included, is presented in the PRISMA flow diagram shown in Fig. 1. A total of seven in vitro studies met the inclusion criteria and were analyzed in this systematic review, all of which evaluated the cytotoxic effects of SDF and related silver or fluoride-based compounds on human dental pulp cells. Although both in vitro and ex vivo studies were considered eligible during study selection, no ex vivo studies specifically investigating the cytotoxic or biological effects of SDF on human dental pulp cells met the inclusion criteria. The included studies were published between 2022 and 2024 and employed a variety of experimental platforms.Fig. 1PRISMA flow diagram of the study selection process. PRISMA flow diagram of the study selection process. Across studies, the concentration of SDF tested varied widely, from very low dilutions (0.0001–0.01%) to clinically used concentrations (3.8–38%), enabling assessment of both low-dose and high-dose biological responses. In addition to concentration differences, studies evaluated various SDF formulations and commercial products, including conventional SDF, ammonia-free silver fluoride formulations, and potassium iodide (KI)-containing systems, or other clinical solutions such as Bioakt and sodium hypochlorite. Exposure durations ranged from 30 s to 7 days, allowing evaluation of both immediate and extended cytotoxic effects. Most studies employed cell viability assays (MTT, CyQuant, IC50 calculations, colorimetric viability methods) as primary outcome measures. These were frequently supplemented by cell migration assays, apoptosis and necrosis analyses, cytoskeletal staining, reactive oxygen species (ROS) production, histomorphometric evaluation, or alkaline phosphatase activity, enabling broader characterization of cellular responses. Collectively, these studies consistently demonstrated a dose-dependent cytotoxic effect of SDF on pulpal cells, with high concentrations showing severe cytotoxicity, while extremely low dilutions (0.0038–0.0001%) showed variable findings ranging from reduced cytotoxicity to enhanced cell proliferation and improved biocompatibility, particularly when used in combination with KI. Quality of the included studies The ToxRtool was applied to all seven in vitro studies. All the included studies scored between 15 and 16. No studies were excluded based on methodological quality. The detailed quality assessment scores are presented in Table 1. The assessment comprises five methodological domains. While all studies demonstrated a high risk in the test substance identification domain (D1) and four studies showed an unclear risk in the study design description domain (D3), all studies were rated as low risk in test system characterisation (D2), results documentation (D4), and plausibility of study design and data (D5). These findings indicate that the included studies were of generally high methodological quality despite minor reporting limitations. A visual summary of the domain-wise methodological quality assessment of all included studies using the ToxRTool criteria provided in the traffic light plot shown in Fig. 2.Table 1Quality assessment of included in vitro studies using the ToxRTool.Table 1Group/CriteriaHu et al. (2022)Oropeza et al. (2022)Srisomboon et al. (2022)García Bernal et al. (2022)López García et al. (2024)Maru et al. (2024)Khalil et al. (2024)Group I – Test Substance Identification1. Test substance identified✓✓✓✓✓✓✓2. Purity of substance given✗✗✗✗✗✗✗3. Source/origin of substance✓✓✓✓✓✓✓4. Physicochemical properties provided✗✗✗✗✗✗✗Group II – Test System Characterisation5. Test system described✓✓✓✓✓✓✓6. Source/origin of test system✓✓✓✓✓✓✓7. Cultivation/maintenance conditions✓✓✓✓✓✓✓Group III – Study Design Description8. Method of administration✓✓✓✓✓✓✓9. Doses or concentrations specified✓✓✓✓✓✓✓10. Frequency/duration of exposure explained✓✓✓✓✓✓✓11. Negative controls included✓✓✓✓✓✓✓12. Positive controls included✗✓✗✗✗✓✓13. Number of replicates given✓✓✓✓✓✓✓Group IV – Results Documentation14. Endpoints and methods clearly described✓✓✓✓✓✓✓15. Study results transparent and complete✓✓✓✓✓✓✓16. Statistical methods applied✓✓✓✓✓✓✓Group V – Plausibility of Study Design & Data17. Study design appropriate✓✓✓✓✓✓✓18. Quantitative results reliable✓✓✓✓✓✓✓Total Score (✓ only)15161515151616Fig. 2Risk of bias assessment of included studies. Table 1Quality assessment of included in vitro studies using the ToxRTool.Table 1Group/CriteriaHu et al. (2022)Oropeza et al. (2022)Srisomboon et al. (2022)García Bernal et al. (2022)López García et al. (2024)Maru et al. (2024)Khalil et al. (2024)Group I – Test Substance Identification1. Test substance identified✓✓✓✓✓✓✓2. Purity of substance given✗✗✗✗✗✗✗3. Source/origin of substance✓✓✓✓✓✓✓4. Physicochemical properties provided✗✗✗✗✗✗✗Group II – Test System Characterisation5. Test system described✓✓✓✓✓✓✓6. Source/origin of test system✓✓✓✓✓✓✓7. Cultivation/maintenance conditions✓✓✓✓✓✓✓Group III – Study Design Description8. Method of administration✓✓✓✓✓✓✓9. Doses or concentrations specified✓✓✓✓✓✓✓10. Frequency/duration of exposure explained✓✓✓✓✓✓✓11. Negative controls included✓✓✓✓✓✓✓12. Positive controls included✗✓✗✗✗✓✓13. Number of replicates given✓✓✓✓✓✓✓Group IV – Results Documentation14. Endpoints and methods clearly described✓✓✓✓✓✓✓15. Study results transparent and complete✓✓✓✓✓✓✓16. Statistical methods applied✓✓✓✓✓✓✓Group V – Plausibility of Study Design & Data17. Study design appropriate✓✓✓✓✓✓✓18. Quantitative results reliable✓✓✓✓✓✓✓Total Score (✓ only)15161515151616 Quality assessment of included in vitro studies using the ToxRTool. Risk of bias assessment of included studies. Qualitative assessment of data The included in-vitro studies demonstrate a consistent pattern of dose-dependent cytotoxicity of SDF on human dental pulp cells, regardless of cell type or methodological variation. Across the spectrum of experiments, higher SDF concentrations particularly full-strength 38% solutions uniformly resulted in significant reductions in cell viability, significant apoptosis induction, and structural or functional compromise of DPSCs and SHEDs. Although differences in cytotoxicity may be influenced by formulation characteristics, the quantitative meta-analysis included only conventional SDF preparations and was primarily designed to evaluate concentration-dependent effects. Modified formulations, such as potassium iodide–containing systems, ammonia-free SDF, and other experimental preparations, were considered only in the qualitative synthesis because of insufficient comparable data for quantitative pooling. Therefore, the subgroup analyses were based on SDF concentration rather than formulation type. Several studies further highlighted that even extremely low concentrations (0.001–0.01%) can exhibit measurable cytotoxicity. Nevertheless, very dilute SDF (≤0.0038–0.0001%) can be biocompatible, supporting cell proliferation, migration, or differentiation potential, and in some cases stimulating the release of dentinogenic growth factors. Overall, while SDF at high concentrations poses cytotoxic risks in vitro, careful dilution and formulation adjustments may optimize its therapeutic benefit by balancing antimicrobial efficacy with cellular compatibility, supporting its clinical use. The methodological variables and main findings of the included studies are depicted in Table 2.Table 2Characteristics and main findings of included in vitro studies.Table 2S.NoAuthor(s), YearTitleObjectiveType of StudyCell Type/TissueSDF Conc. & BrandExposure DurationMethodsPulp/Cell EffectsConclusion1Srisomboon et al., 2022Effects of Silver Diamine Nitrate and SDF on Dentin Remineralization and CytotoxicityTo Compare remineralization & cytotoxicityIn vitroHuman DPSCs25 μL of 38% SDF, (TopamineTM; Dentalife, Victoria, Australia)•SDF was applied for 30 sMTT, FTIR-ATR, SEM-EDX, SRXTM•SDF demonstrated superior in vitro apatite formation compared to SDN•cell viability was reduced after treatment with SDF and SDN by approximately 8% and 13%, respectively.SDF highly cytotoxic to pulp cells despite remineralization2García-Bernal et al., 2022The cytocompatibility of silver diamine fluoride on mesenchymal stromal cells from human exfoliated deciduous teeth: An in vitro studyCompare cytotoxicity of Riva Star and e-SDFIn vitroSHED0.1%, 0.01%, 0.005% (formed by dilution of Riva Star (SDI Dental Limited) and e-SDF (Kids-e-Dental)•SDF application duration Not specified•exposure times of 24, 48, 72 hIC50, MTT, cell migration, cell cytoskeleton staining, cell apoptosis, generation of intracellular ROS, and ion chromatography•Riva Star Step 2 showed the same cell metabolic activity when compared to the control condition at any time and concentration. Meanwhile, e-SDF displayed high cytotoxicity at any time and any concentration (p < 0.001), whereas Riva Star Step 1 displayed high cytotoxicity at any time at 0.1% and 0.01% (p < 0.001).•Only e-SDF showed a statistically significant decreased cell migration rate (p < 0.001) at all times and in all concentrations. At 0.1%, e-SDF and Riva Star Step 1 only showed 4.37% and 4.47% of viable cells, respectivelyRiva Star has better in vitro cytocompatibility on SHEDs than does e-SDF3Hu et al., 2022Characterization of silver diamine fluoride cytotoxicity using microfluidic tooth-on-a-chip and gingival equivalentsAssess SDF toxicity on DPSC & gingival equivalentsIn vitroHuman DPSCs0.0001% to 0.01%% Conc, formed by diluting150 μL of 38% SDF (Advantage Arrest Silver Diamine Fluoride, Elevate Oral Care, Florida)•SDF application duration Not specifiedMTT assay, histomorphometric analysis•DPSC exposed directly (without a dentin barrier) to media containing SDF (0.0001–0.01%) under static culture conditions showed a dose-dependent reduction in cell viability.•The cellular viability was less than 50% for concentrations above 0.001% (IC50 = 0.001%; 95% confidence intervals: 0.0009 – 0.0014).SDF was found to be cytotoxic to DPSC at extremely low concentrations (0.001%)4Oropeza et al., 2022Cytotoxicity analysis of DPSCs after SDFEvaluate DPSCs viabilityIn vitroHuman DPSCs10-3, 10-4, and 10-5, 38% SDF(Advantage ArrestTM, Elevate Oral Care, LLC, WestPalm Beach, Fla., USA)•SDF application duration Not specified•Assay done at 24 hcolorimetric detection assay•Cells exposed to dilution of 38 percent SDF 10-3 had an average cell viability of 17.0 ± 3.5 percent. Cells exposed to SDF 10-4 and 10-5 had an average cell viability of 101 ± 2.5 percent and 94 ± 4.4 percent, respectively.•Dilution of 10-3 had significantly lower cell viability than the negative control (P < 0.001). Dilution of 10-4 and 10-5 SDF had significantly higher cell viability than the positive control (P < 0.001) and cells treated with a dilution of 10-3 (P < 0.001).This study demonstrates the dose-dependent cytotoxicity of SDF to hDPSC.5López-García et al., 2024In vitro biocompatibility of ammonia-free silver fluoride vs. SDFCompare ammonia-free silver fluoride vs. SDFIn vitroHuman DPSCs0.005%, 0.0005%, and 0.0001% dilution of Riva Star (SDF) (SDI, Victoria, Australia)Exposure duration 24, 48, and 72 hMTT, IC50, wound healing assay, cell cytoskeleton staining, apoptosis and necrosis analysis, and ROS production•SDF and AgF alone were highly cytotoxic: poor viability at all tested concentrations and times.•Both induced apoptosis, cytoskeletal disruption, delayed migration, and increased ROS.•On the contrary, no cells were observed in SDF or AgF groups at 0.005% and 0.0005% concentrations. In accordance with the MTT and cell migration assays, the combination of SDF or AgF with KI improved the number and morphology of cells, especially at 0.0001%•KI alone showed biocompatibility comparable to controls (>93% live cells).•Adding KI to SDF or AgF improved cytocompatibility (higher viability, better morphology, reduced apoptosis/ROS), especially at 0.0001–0.0005%.•Riva Star Aqua (ammonia-free) was less cytotoxic than Riva Star.Within the limitations of the present in vitro study, Riva Star Aqua exhibits a lower cytotoxicity than Riva Star on human dental pulp stem cells.6Maru et al., 2024Evaluation of cytotoxicity of 3.8% SDF and BioAKT solutions on the viability of dental pulp stem cellsCompare SDF vs. BioAKT with NaOCl as irrigantIn vitroHuman DPSCs3.8% SDF diluted from 38% SDF (FAgamin; Argentina) using disinfected distilled waterFurther dilutions of 1:100,1:20 &1:10 was doneExposure durations were set at 60 min, 10 min, and 24 h,MTT, apoptosis and ALP activity•Across multiple dilutions and incubation periods (10 min, 60 min, 24 h), 3.8% SDF showed no cytotoxic effects on DPSCs.•The highest percentage of live cells was recorded in BioAKT (98.90 ± 1.66), followed by 3.8% SDF (95.68 ± 3.01), 5.25% NaOCl (93.47 ± 2.79), and the control (92.30 ± 4.36).•Alkaline phosphatase (ALP) activity, a marker for osteogenic differentiation, was significantly higher in DPSCs treated with 3.8% SDF compared to NaOCl, indicating better proliferation and differentiation potential.Different doses of 3.8% SDF revealed encouraging outcomes in terms of viability, proliferation and long-term ALP functioning potential.7Khalil et al., 2024Silver diamine fluoride: A stem cell cytotoxicity and dentin growth factor release in-vitro studyAssess effect of 38% SDF and its dilutions on SHED + GF releaseIn vitroHuman pulp stem cells38%, 3.8%, 0.38%, 0.038%, 0.0038% (other solutions were prepared by diluting 38% solution)Exposure duration 2, 5, 7 daysCyQuant, MTT assay, ELISA•High concentrations (38–0.38%) killed SHED.•At 0.038%, cell viability was reduced, while at 0.0038% proliferation was enhanced.•Both 38% and 0.0038% SDF stimulated dentinogenic growth factor release (TGF-β1, BMP-2, FGF; VEGF release was higher at 0.0038%).•At 0.0038%, SDF was non-cytotoxic, enhanced proliferation, and did not inhibit odontogenic differentiation.Strongly toxic at high concentrations. Very low dilution (0.0038%) was safe, promoted cell growth, and stimulated dentin repair factors.Abbreviation:- SDF–Silver Diamine Fluoride; SDN–Silver Diamine Nitrate; DPSC/hDPSC–(Human) Dental Pulp Stem Cells; SHED–Stem Cells from Human Exfoliated Deciduous Teeth; AgF–Silver Fluoride; KI–Potassium Iodide; MTT–3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay; IC50–Half Maximal Inhibitory Concentration; ROS–Reactive Oxygen Species; FTIR-ATR–Fourier Transform Infrared Spectroscopy–Attenuated Total Reflectance; SEM-EDX–Scanning Electron Microscopy–Energy Dispersive X-ray; SRXTM–Synchrotron Radiation X-ray Tomographic Microscopy; ALP–Alkaline Phosphatase; NaOCl–Sodium Hypochlorite; ELISA–Enzyme-Linked Immunosorbent Assay; TGF-β1–Transforming Growth Factor Beta-1; BMP-2–Bone Morphogenetic Protein-2; GF Growth Factor; FGF–Fibroblast Growth Factor; VEGF–Vascular Endothelial Growth Factor. Table 2Characteristics and main findings of included in vitro studies.Table 2S.NoAuthor(s), YearTitleObjectiveType of StudyCell Type/TissueSDF Conc. & BrandExposure DurationMethodsPulp/Cell EffectsConclusion1Srisomboon et al., 2022Effects of Silver Diamine Nitrate and SDF on Dentin Remineralization and CytotoxicityTo Compare remineralization & cytotoxicityIn vitroHuman DPSCs25 μL of 38% SDF, (TopamineTM; Dentalife, Victoria, Australia)•SDF was applied for 30 sMTT, FTIR-ATR, SEM-EDX, SRXTM•SDF demonstrated superior in vitro apatite formation compared to SDN•cell viability was reduced after treatment with SDF and SDN by approximately 8% and 13%, respectively.SDF highly cytotoxic to pulp cells despite remineralization2García-Bernal et al., 2022The cytocompatibility of silver diamine fluoride on mesenchymal stromal cells from human exfoliated deciduous teeth: An in vitro studyCompare cytotoxicity of Riva Star and e-SDFIn vitroSHED0.1%, 0.01%, 0.005% (formed by dilution of Riva Star (SDI Dental Limited) and e-SDF (Kids-e-Dental)•SDF application duration Not specified•exposure times of 24, 48, 72 hIC50, MTT, cell migration, cell cytoskeleton staining, cell apoptosis, generation of intracellular ROS, and ion chromatography•Riva Star Step 2 showed the same cell metabolic activity when compared to the control condition at any time and concentration. Meanwhile, e-SDF displayed high cytotoxicity at any time and any concentration (p < 0.001), whereas Riva Star Step 1 displayed high cytotoxicity at any time at 0.1% and 0.01% (p < 0.001).•Only e-SDF showed a statistically significant decreased cell migration rate (p < 0.001) at all times and in all concentrations. At 0.1%, e-SDF and Riva Star Step 1 only showed 4.37% and 4.47% of viable cells, respectivelyRiva Star has better in vitro cytocompatibility on SHEDs than does e-SDF3Hu et al., 2022Characterization of silver diamine fluoride cytotoxicity using microfluidic tooth-on-a-chip and gingival equivalentsAssess SDF toxicity on DPSC & gingival equivalentsIn vitroHuman DPSCs0.0001% to 0.01%% Conc, formed by diluting150 μL of 38% SDF (Advantage Arrest Silver Diamine Fluoride, Elevate Oral Care, Florida)•SDF application duration Not specifiedMTT assay, histomorphometric analysis•DPSC exposed directly (without a dentin barrier) to media containing SDF (0.0001–0.01%) under static culture conditions showed a dose-dependent reduction in cell viability.•The cellular viability was less than 50% for concentrations above 0.001% (IC50 = 0.001%; 95% confidence intervals: 0.0009 – 0.0014).SDF was found to be cytotoxic to DPSC at extremely low concentrations (0.001%)4Oropeza et al., 2022Cytotoxicity analysis of DPSCs after SDFEvaluate DPSCs viabilityIn vitroHuman DPSCs10-3, 10-4, and 10-5, 38% SDF(Advantage ArrestTM, Elevate Oral Care, LLC, WestPalm Beach, Fla., USA)•SDF application duration Not specified•Assay done at 24 hcolorimetric detection assay•Cells exposed to dilution of 38 percent SDF 10-3 had an average cell viability of 17.0 ± 3.5 percent. Cells exposed to SDF 10-4 and 10-5 had an average cell viability of 101 ± 2.5 percent and 94 ± 4.4 percent, respectively.•Dilution of 10-3 had significantly lower cell viability than the negative control (P < 0.001). Dilution of 10-4 and 10-5 SDF had significantly higher cell viability than the positive control (P < 0.001) and cells treated with a dilution of 10-3 (P < 0.001).This study demonstrates the dose-dependent cytotoxicity of SDF to hDPSC.5López-García et al., 2024In vitro biocompatibility of ammonia-free silver fluoride vs. SDFCompare ammonia-free silver fluoride vs. SDFIn vitroHuman DPSCs0.005%, 0.0005%, and 0.0001% dilution of Riva Star (SDF) (SDI, Victoria, Australia)Exposure duration 24, 48, and 72 hMTT, IC50, wound healing assay, cell cytoskeleton staining, apoptosis and necrosis analysis, and ROS production•SDF and AgF alone were highly cytotoxic: poor viability at all tested concentrations and times.•Both induced apoptosis, cytoskeletal disruption, delayed migration, and increased ROS.•On the contrary, no cells were observed in SDF or AgF groups at 0.005% and 0.0005% concentrations. In accordance with the MTT and cell migration assays, the combination of SDF or AgF with KI improved the number and morphology of cells, especially at 0.0001%•KI alone showed biocompatibility comparable to controls (>93% live cells).•Adding KI to SDF or AgF improved cytocompatibility (higher viability, better morphology, reduced apoptosis/ROS), especially at 0.0001–0.0005%.•Riva Star Aqua (ammonia-free) was less cytotoxic than Riva Star.Within the limitations of the present in vitro study, Riva Star Aqua exhibits a lower cytotoxicity than Riva Star on human dental pulp stem cells.6Maru et al., 2024Evaluation of cytotoxicity of 3.8% SDF and BioAKT solutions on the viability of dental pulp stem cellsCompare SDF vs. BioAKT with NaOCl as irrigantIn vitroHuman DPSCs3.8% SDF diluted from 38% SDF (FAgamin; Argentina) using disinfected distilled waterFurther dilutions of 1:100,1:20 &1:10 was doneExposure durations were set at 60 min, 10 min, and 24 h,MTT, apoptosis and ALP activity•Across multiple dilutions and incubation periods (10 min, 60 min, 24 h), 3.8% SDF showed no cytotoxic effects on DPSCs.•The highest percentage of live cells was recorded in BioAKT (98.90 ± 1.66), followed by 3.8% SDF (95.68 ± 3.01), 5.25% NaOCl (93.47 ± 2.79), and the control (92.30 ± 4.36).•Alkaline phosphatase (ALP) activity, a marker for osteogenic differentiation, was significantly higher in DPSCs treated with 3.8% SDF compared to NaOCl, indicating better proliferation and differentiation potential.Different doses of 3.8% SDF revealed encouraging outcomes in terms of viability, proliferation and long-term ALP functioning potential.7Khalil et al., 2024Silver diamine fluoride: A stem cell cytotoxicity and dentin growth factor release in-vitro studyAssess effect of 38% SDF and its dilutions on SHED + GF releaseIn vitroHuman pulp stem cells38%, 3.8%, 0.38%, 0.038%, 0.0038% (other solutions were prepared by diluting 38% solution)Exposure duration 2, 5, 7 daysCyQuant, MTT assay, ELISA•High concentrations (38–0.38%) killed SHED.•At 0.038%, cell viability was reduced, while at 0.0038% proliferation was enhanced.•Both 38% and 0.0038% SDF stimulated dentinogenic growth factor release (TGF-β1, BMP-2, FGF; VEGF release was higher at 0.0038%).•At 0.0038%, SDF was non-cytotoxic, enhanced proliferation, and did not inhibit odontogenic differentiation.Strongly toxic at high concentrations. Very low dilution (0.0038%) was safe, promoted cell growth, and stimulated dentin repair factors.Abbreviation:- SDF–Silver Diamine Fluoride; SDN–Silver Diamine Nitrate; DPSC/hDPSC–(Human) Dental Pulp Stem Cells; SHED–Stem Cells from Human Exfoliated Deciduous Teeth; AgF–Silver Fluoride; KI–Potassium Iodide; MTT–3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay; IC50–Half Maximal Inhibitory Concentration; ROS–Reactive Oxygen Species; FTIR-ATR–Fourier Transform Infrared Spectroscopy–Attenuated Total Reflectance; SEM-EDX–Scanning Electron Microscopy–Energy Dispersive X-ray; SRXTM–Synchrotron Radiation X-ray Tomographic Microscopy; ALP–Alkaline Phosphatase; NaOCl–Sodium Hypochlorite; ELISA–Enzyme-Linked Immunosorbent Assay; TGF-β1–Transforming Growth Factor Beta-1; BMP-2–Bone Morphogenetic Protein-2; GF Growth Factor; FGF–Fibroblast Growth Factor; VEGF–Vascular Endothelial Growth Factor. Characteristics and main findings of included in vitro studies. •SDF was applied for 30 s SDF was applied for 30 s •SDF demonstrated superior in vitro apatite formation compared to SDN SDF demonstrated superior in vitro apatite formation compared to SDN •cell viability was reduced after treatment with SDF and SDN by approximately 8% and 13%, respectively. cell viability was reduced after treatment with SDF and SDN by approximately 8% and 13%, respectively. •SDF application duration Not specified SDF application duration Not specified •exposure times of 24, 48, 72 h exposure times of 24, 48, 72 h •Riva Star Step 2 showed the same cell metabolic activity when compared to the control condition at any time and concentration. Meanwhile, e-SDF displayed high cytotoxicity at any time and any concentration (p < 0.001), whereas Riva Star Step 1 displayed high cytotoxicity at any time at 0.1% and 0.01% (p < 0.001). Riva Star Step 2 showed the same cell metabolic activity when compared to the control condition at any time and concentration. Meanwhile, e-SDF displayed high cytotoxicity at any time and any concentration (p < 0.001), whereas Riva Star Step 1 displayed high cytotoxicity at any time at 0.1% and 0.01% (p < 0.001). •Only e-SDF showed a statistically significant decreased cell migration rate (p < 0.001) at all times and in all concentrations. At 0.1%, e-SDF and Riva Star Step 1 only showed 4.37% and 4.47% of viable cells, respectively Only e-SDF showed a statistically significant decreased cell migration rate (p < 0.001) at all times and in all concentrations. At 0.1%, e-SDF and Riva Star Step 1 only showed 4.37% and 4.47% of viable cells, respectively •SDF application duration Not specified SDF application duration Not specified •DPSC exposed directly (without a dentin barrier) to media containing SDF (0.0001–0.01%) under static culture conditions showed a dose-dependent reduction in cell viability. DPSC exposed directly (without a dentin barrier) to media containing SDF (0.0001–0.01%) under static culture conditions showed a dose-dependent reduction in cell viability. •The cellular viability was less than 50% for concentrations above 0.001% (IC50 = 0.001%; 95% confidence intervals: 0.0009 – 0.0014). The cellular viability was less than 50% for concentrations above 0.001% (IC50 = 0.001%; 95% confidence intervals: 0.0009 – 0.0014). •SDF application duration Not specified SDF application duration Not specified •Assay done at 24 h Assay done at 24 h •Cells exposed to dilution of 38 percent SDF 10-3 had an average cell viability of 17.0 ± 3.5 percent. Cells exposed to SDF 10-4 and 10-5 had an average cell viability of 101 ± 2.5 percent and 94 ± 4.4 percent, respectively. Cells exposed to dilution of 38 percent SDF 10-3 had an average cell viability of 17.0 ± 3.5 percent. Cells exposed to SDF 10-4 and 10-5 had an average cell viability of 101 ± 2.5 percent and 94 ± 4.4 percent, respectively. •Dilution of 10-3 had significantly lower cell viability than the negative control (P < 0.001). Dilution of 10-4 and 10-5 SDF had significantly higher cell viability than the positive control (P < 0.001) and cells treated with a dilution of 10-3 (P < 0.001). Dilution of 10-3 had significantly lower cell viability than the negative control (P < 0.001). Dilution of 10-4 and 10-5 SDF had significantly higher cell viability than the positive control (P < 0.001) and cells treated with a dilution of 10-3 (P < 0.001). •SDF and AgF alone were highly cytotoxic: poor viability at all tested concentrations and times. SDF and AgF alone were highly cytotoxic: poor viability at all tested concentrations and times. •Both induced apoptosis, cytoskeletal disruption, delayed migration, and increased ROS. Both induced apoptosis, cytoskeletal disruption, delayed migration, and increased ROS. •On the contrary, no cells were observed in SDF or AgF groups at 0.005% and 0.0005% concentrations. In accordance with the MTT and cell migration assays, the combination of SDF or AgF with KI improved the number and morphology of cells, especially at 0.0001% On the contrary, no cells were observed in SDF or AgF groups at 0.005% and 0.0005% concentrations. In accordance with the MTT and cell migration assays, the combination of SDF or AgF with KI improved the number and morphology of cells, especially at 0.0001% •KI alone showed biocompatibility comparable to controls (>93% live cells). KI alone showed biocompatibility comparable to controls (>93% live cells). •Adding KI to SDF or AgF improved cytocompatibility (higher viability, better morphology, reduced apoptosis/ROS), especially at 0.0001–0.0005%. Adding KI to SDF or AgF improved cytocompatibility (higher viability, better morphology, reduced apoptosis/ROS), especially at 0.0001–0.0005%. •Riva Star Aqua (ammonia-free) was less cytotoxic than Riva Star. Riva Star Aqua (ammonia-free) was less cytotoxic than Riva Star. •Across multiple dilutions and incubation periods (10 min, 60 min, 24 h), 3.8% SDF showed no cytotoxic effects on DPSCs. Across multiple dilutions and incubation periods (10 min, 60 min, 24 h), 3.8% SDF showed no cytotoxic effects on DPSCs. •The highest percentage of live cells was recorded in BioAKT (98.90 ± 1.66), followed by 3.8% SDF (95.68 ± 3.01), 5.25% NaOCl (93.47 ± 2.79), and the control (92.30 ± 4.36). The highest percentage of live cells was recorded in BioAKT (98.90 ± 1.66), followed by 3.8% SDF (95.68 ± 3.01), 5.25% NaOCl (93.47 ± 2.79), and the control (92.30 ± 4.36). •Alkaline phosphatase (ALP) activity, a marker for osteogenic differentiation, was significantly higher in DPSCs treated with 3.8% SDF compared to NaOCl, indicating better proliferation and differentiation potential. Alkaline phosphatase (ALP) activity, a marker for osteogenic differentiation, was significantly higher in DPSCs treated with 3.8% SDF compared to NaOCl, indicating better proliferation and differentiation potential. •High concentrations (38–0.38%) killed SHED. High concentrations (38–0.38%) killed SHED. •At 0.038%, cell viability was reduced, while at 0.0038% proliferation was enhanced. At 0.038%, cell viability was reduced, while at 0.0038% proliferation was enhanced. •Both 38% and 0.0038% SDF stimulated dentinogenic growth factor release (TGF-β1, BMP-2, FGF; VEGF release was higher at 0.0038%). Both 38% and 0.0038% SDF stimulated dentinogenic growth factor release (TGF-β1, BMP-2, FGF; VEGF release was higher at 0.0038%). •At 0.0038%, SDF was non-cytotoxic, enhanced proliferation, and did not inhibit odontogenic differentiation. At 0.0038%, SDF was non-cytotoxic, enhanced proliferation, and did not inhibit odontogenic differentiation. Abbreviation:- SDF–Silver Diamine Fluoride; SDN–Silver Diamine Nitrate; DPSC/hDPSC–(Human) Dental Pulp Stem Cells; SHED–Stem Cells from Human Exfoliated Deciduous Teeth; AgF–Silver Fluoride; KI–Potassium Iodide; MTT–3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay; IC50–Half Maximal Inhibitory Concentration; ROS–Reactive Oxygen Species; FTIR-ATR–Fourier Transform Infrared Spectroscopy–Attenuated Total Reflectance; SEM-EDX–Scanning Electron Microscopy–Energy Dispersive X-ray; SRXTM–Synchrotron Radiation X-ray Tomographic Microscopy; ALP–Alkaline Phosphatase; NaOCl–Sodium Hypochlorite; ELISA–Enzyme-Linked Immunosorbent Assay; TGF-β1–Transforming Growth Factor Beta-1; BMP-2–Bone Morphogenetic Protein-2; GF Growth Factor; FGF–Fibroblast Growth Factor; VEGF–Vascular Endothelial Growth Factor. Quantitative assessment of data Across all included SDF concentrations, the meta-analysis revealed a strong and consistent dose-dependent cytotoxic effect on human dental pulp cells. To minimize methodological variability, only studies employing the MTT assay were included in the quantitative synthesis. A random-effects model was used for the meta-analysis because methodological and biological heterogeneity was anticipated among the included studies. Although the studies evaluated different SDF formulations and exposure durations, they reported sufficiently comparable concentration data to permit pooling according to concentration ranges. However, because the included studies differed in experimental conditions, cell types, SDF formulations, and exposure protocols, the pooled estimates should be interpreted as exploratory evidence of concentration-dependent trends rather than direct measures of clinical cytotoxicity. Subgroup analyses were performed according to concentration ranges reported in the included studies. The available data naturally clustered into three concentration categories (0.00001–0.0005%, 0.001–0.005%, and ≥0.008%), allowing studies with similar exposure levels to be pooled while facilitating evaluation of concentration-dependent effects on cell viability. At very low concentrations (0.00001–0.0005%), cell viability remained high, with an overall pooled estimate of 0.99 (95% CI: 0.97–1.00), indicating minimal cytotoxicity. Subgroup analyses showed pooled viability estimates ranging from 0.96 to 1.00 across the individual concentration categories. Despite moderate heterogeneity (I2 = 74.3%, P = 0.0007), significant subgroup differences were observed (P = 0.0197), indicating concentration-dependent variation even within the very low concentration range. These findings are illustrated in Fig. 3.Fig. 3Forest plot of pooled estimates stratified by very low concentration. Forest plot of pooled estimates stratified by very low concentration. At low concentrations (0.001–0.005%), cell viability declined markedly, with a pooled estimate of 0.73 (95% CI: 0.46–0.93), indicating a significant reduction in viability compared with the very low concentration subgroup. Considerable heterogeneity was observed among the included studies (I2 = 99.0%, P < 0.00001), reflecting variability in experimental conditions, cell populations, and exposure protocols. Nevertheless, the pooled analysis consistently demonstrated that SDF concentrations of 0.001% or greater were associated with substantial reductions in pulp cell viability. The subgroup analysis for this concentration range is presented in Fig. 4.Fig. 4Forest plot of pooled estimates stratified by low moderate concentration. Forest plot of pooled estimates stratified by low moderate concentration. At moderate-to-high concentrations (≥0.008%), the cytotoxic effect became profound, with the pooled cell viability estimate decreasing to 0.14 (95% CI: 0.00–0.41), indicating severe cytotoxicity. Subgroup pooled estimates ranged from 0.03 to 0.45, with the lowest viability observed at 0.008% and 0.01% SDF. Although substantial heterogeneity was present (I2 = 98.2%, P < 0.00001), subgroup differences were not statistically significant (P = 0.2844), indicating consistently severe cytotoxicity across the higher concentration range. These results are shown in Fig. 5.Fig. 5Forest plot of pooled estimates stratified by moderate concentration. Forest plot of pooled estimates stratified by moderate concentration. Collectively, these findings confirm that SDF is biologically safe only at very low concentrations, while concentrations at or above 0.001% lead to a rapid and consistent reduction in pulp cell survival, with extreme toxicity evident beyond this threshold. Considerable statistical heterogeneity was observed among the included studies, with I2 values ranging from 74.3% to 99.0% across the pooled analyses. This heterogeneity likely reflects differences in study design, cell populations, SDF concentrations, and experimental conditions and should be considered when interpreting the pooled estimates. Taken together, the majority of studies identified IC50 thresholds at or below 0.001% (Hu et al., 2022; López-García et al., 2024, García-Bernal et al.), reinforcing that SDF induces measurable cytotoxicity even at low concentrations, with potency varying by product formulation. Separately, Oropeza et al. (2022) documented an IC50 as low as 0.0004%, representing the lowest threshold among all studies and highlighting the extreme sensitivity of pulp cells to SDF in some conditions. Overall, despite some variation between commercial formulations, the majority of studies converged around IC50 values at or below 0.001%, reinforcing that SDF exerts cytotoxic effects at exceptionally low concentrations. The graphical presentation of pooled cell viability proportions is presented in Fig. 3, Fig. 4, Fig. 5. Discussion This systematic review and meta-analysis demonstrate a clear and consistent dose-dependent cytotoxic effect of silver diamine fluoride (SDF) on human dental pulp cells. Across all included in vitro studies, higher SDF concentrations, particularly full-strength 38% solutions or minimally diluted eluates, were associated with substantial reductions in cell viability, induction of apoptosis, disruption of cytoskeletal organization, and impaired cell migration. In contrast, very low SDF dilutions were frequently non-cytotoxic and promoted cellular proliferation. Oropeza et al. showed that exposure of human dental pulp stem cells to a 10−3 dilution of 38% SDF reduced cell viability to approximately 17%, while lower dilutions (10−4 and 10−5) were non-cytotoxic.6 Quantitative synthesis of IC50 and viability data supports a steep concentration–response relationship, indicating a narrow therapeutic window. These findings support earlier reviews, including Zaeneldin et al.,4 which reported pulpal inflammation and cellular damage following direct exposure to high-concentration SDF. The observed cytotoxicity is consistent with established mechanisms of silver and fluoride toxicity. Srisomboon et al.7 showed that silver and fluoride ions induce oxidative stress, glutathione depletion, lipid peroxidation, apoptosis, and inflammation in pulp cells. Additionally, the high alkalinity of SDF (pH 9–10) may further impair cell proliferation and mineralization after direct contact, as demonstrated by Hu et al.8 Kim et al.9 demonstrated that 38% SDF reduced pulpal cell viability and caused acute pulp necrosis through glutathione depletion. Similarly, silver nanoparticles have been shown to induce oxidative stress and glutathione depletion, contributing to mitochondrial dysfunction and apoptosis.10 Rossi et al.3 also reported irreversible pulp damage following direct or near-pulpal SDF exposure, with outcomes influenced by residual dentin thickness. Microfluidic “tooth-on-a-chip” models have further reinforced these observations by demonstrating that direct exposure or penetration through thin dentin barriers (≤1 mm) leads to extensive pulp cell death. Hu et al. reported that dental pulp stem cell viability dropped to 0–31% when SDF diffused through dentin discs ≤1.0 mm thick, whereas thicker dentin (1.5 mm) provided partial protection, highlighting the critical role of residual dentin thickness in modulating cytotoxicity.8 Differences in SDF formulations may partly explain variability in cytotoxicity. Ammonia-free formulations, such as Riva Star, showed improved cytocompatibility, while very low SDF concentrations (0.0001–0.0038%) promoted cell proliferation and growth factor release.11,12 13 An apparent exception to the overall cytotoxicity trend was reported by Maru et al., who observed high DPSC viability following exposure to 3.8% SDF. However, this study evaluated diluted SDF preparations (1:10–1:100) within a regenerative endodontic model rather than direct cytotoxicity thresholds. The overall evidence supports a dose-dependent reduction in pulp cell viability.14 Similarly, Hiraishi et al.15 reported that 3.8% SDF exhibited strong antimicrobial activity against Enterococcus faecalis while causing less damage to root dentin and surrounding cells compared with conventional irrigants. From a clinical perspective, these findings suggest caution regarding the use of SDF for direct pulp capping or application over exposures with minimal residual dentin (<1 mm), where penetration may result in irreversible pulpitis or necrosis. Indirect pulp therapy remains appropriate when sufficient dentin is present. Low-concentration protocols, potassium iodide application, or ammonia-free formulations may improve biocompatibility and should be considered during treatment planning. Despite methodological differences in cell type, SDF formulation, and exposure duration, all included studies assessed the same primary outcome human dental pulp cell viability. Therefore, subgroup analyses were based on SDF concentration, the principal determinant of cytotoxicity, rather than experimental variables. The pooled findings indicate overall dose-dependent trends but should be interpreted cautiously because of substantial between study heterogeneity and insufficient comparable data for quantitative analysis of modified SDF formulations. Additional subgroup analyses based on cell type, exposure duration, formulation type, or direct versus dentin-mediated exposure were not feasible because of the limited number of included studies, substantial methodological heterogeneity, and insufficient comparable data across studies. Consequently, the quantitative conclusions should be interpreted as exploratory rather than definitive. The strengths of this review include the comprehensive qualitative and quantitative synthesis of available data across multiple experimental platforms and cell types, allowing consolidation of dispersed evidence and evaluation of dose-dependent effects. The standardized extraction of IC50 values and cell viability outcomes provides clinically relevant benchmarks for safer SDF application. Nevertheless, several limitations should be acknowledged. Methodological heterogeneity in SDF formulations, exposure times, experimental models, and cell culture conditions may have affected reproducibility and limited direct comparison across studies. The quantitative meta-analysis was limited to MTT-based cell viability outcomes and conventional SDF formulations, precluding quantitative synthesis of other biological outcomes and modified SDF formulations. Accordingly, the pooled estimates should be interpreted as general indicators of dose-dependent cytotoxicity rather than precise measures under specific experimental conditions. Taken together, these limitations indicate that the findings of the meta-analysis should be regarded as exploratory rather than definitive and should be interpreted with appropriate caution. Furthermore, the predominance of in vitro evidence and the lack of long-term in vivo studies limit the clinical applicability of these findings. Publication bias was not formally assessed because only seven studies were available, which is below the recommended threshold for reliable funnel plot analysis and statistical testing. Therefore, the potential influence of publication bias cannot be excluded. In addition, negative or non-significant studies may be less likely to be published, potentially leading to an overrepresentation of studies reporting cytotoxic effects. Industrial sponsorship or commercial interests may also influence the reporting of proprietary or modified SDF formulations. Furthermore, studies demonstrating favorable cytocompatibility of modified formulations, such as ammonia-free or potassium iodide–containing products, may be preferentially published, introducing publication and reporting bias. These potential sources of bias should be considered when interpreting the findings of this review. Future research should focus on developing standardized protocols for SDF application that optimize antimicrobial efficacy while minimizing pulpal cytotoxicity. Exploration of formulation modifiers, such as potassium iodide, may further enhance biocompatibility. Well-designed in vivo studies examining pulpal responses to SDF under physiologic conditions, particularly with stratification based on residual dentin thickness, are urgently required. In addition, investigations into the molecular pathways underlying pulp cell apoptosis and regeneration following SDF exposure may provide valuable insights for improving therapeutic outcomes and enhancing the clinical safety of SDF. Conclusion SDF demonstrates strong dose-dependent cytotoxicity, remaining biologically safe only at very low concentrations while clinically used levels show significant pulp cell toxicity. These findings suggest that caution should be exercised when SDF is used in deep carious lesions or in close proximity to the pulp. However, the heterogeneity among included studies highlighted and the exclusive reliance on in vitro evidence the pooled findings should be considered exploratory and interpreted with caution and limit direct clinical extrapolation. Further research is required to develop safer formulations and assess pulpal responses under clinically relevant conditions. Patient's/guardian's consent Not applicable. Ethical clearance Not required. Ethics statement Ethical approval was not required because this study is a systematic review and meta-analysis based exclusively on published literature. Registration Number PROSPERO Registration Number: CRD420251166805. Author contributions Chanchal Kumari: Conceptualization, methodology, formal analysis and investigation, data curation, writing – original draft preparation. Ruchi Singhal: Conceptualization, methodology, formal analysis and investigation, data curation, writing – review and editing, supervision, project administration. Ritu Namdev: Conceptualization, writing – review and editing, supervision. Adarsh Kumar: Methodology, formal analysis and investigation, statistical analysis, writing – review and editing. Shiwani Chawla: Formal analysis and investigation, data curation, writing – review and editing. Khusboo Chhanna: Data curation, writing – review and editing. All authors read and approved the final manuscript and agree to be accountable for all aspects of the work. Human participants statement This study did not involve human participants, human biological samples, or identifiable personal data. Therefore, approval from an institutional ethics committee and informed consent were not required. Animal ethics statement This study did not involve animal subjects or animal-derived materials. Accordingly, approval from an animal ethics committee was not required. Declaration of generative ai and ai-assisted technologies in the writing process During the preparation of this work, the authors used ChatGPT (OpenAI) to assist with improving the language clarity and readability of the manuscript. The use was minimal and limited to language refinement only. All content was thoroughly reviewed and edited by the authors to ensure accuracy, integrity, and compliance with academic standards. The authors take full responsibility for the final content of the manuscript. Sources of funding This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors. Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.